Ping An Biomedical Co., Ltd. (PASW) Form 6-K — Oct 21, 2026
Ping An Biomedical Co., Ltd. (Nasdaq: PASW) announced a 1-for-40 reverse stock split of its class A and class B ordinary shares, effective October 23, 2026, when shares will begin trading on a split-adjusted basis. The split was authorized following a March 18, 2026 EGM and unanimously approved by the board on August 6, 2026. Shares outstanding will fall from roughly 112.9 million class A and 12.3 million class B shares to approximately 2.82 million and 306,250 respectively, with par value rising from $0.0000625 to $0.0025 and a new CUSIP (G5880S139).
Key figures
- Effective Date
- 2026-10-23
- Shares Outstanding
- 112,867,000 class A and 12,250,000 class B ordinary shares pre-split
- Reverse split ratio
- 1:40
- New cusip
- G5880S139
- Pre split par value
- $0.0000625
- Post split par value
- $0.0025
- Post split class A shares
- 2821675
- Post split class B shares
- 306250
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.